Treating malaria in Africa - Sulfadoxzne-pyrimethamine may still have a future despite reports of resistance


Greenwood, B; (2004) Treating malaria in Africa - Sulfadoxzne-pyrimethamine may still have a future despite reports of resistance. BMJ, 328 (7439). pp. 534-535. ISSN 1468-5833 DOI: 10.1136/bmj.328.7439.534

[img]
Preview
Text - Published Version
License: Creative Commons Attribution Non-commercial

Download (56Kb) | Preview
Item Type: Article
Keywords: Falciparum-malaria, mortality, Africa, Antimalarials, therapeutic use, Drug Combinations, Drug Resistance, Human, Malaria, drug therapy, Pyrimethamine, therapeutic use, Sulfadoxine, therapeutic use
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Disease Control
Research Centre: Antimicrobial Resistance Centre (AMR)
Malaria Centre
PubMed ID: 15001479
Web of Science ID: 220091800003
URI: http://researchonline.lshtm.ac.uk/id/eprint/14882

Statistics


Download activity - last 12 months
Downloads since deposit
96Downloads
277Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item